IRIS
MANFREDI, Giulia Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.339
EU - Europa 1.144
AS - Asia 781
SA - Sud America 89
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 51
OC - Oceania 1
Totale 3.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.251
IT - Italia 354
RU - Federazione Russa 346
SG - Singapore 219
CN - Cina 118
IE - Irlanda 107
HK - Hong Kong 105
VN - Vietnam 105
DE - Germania 90
BD - Bangladesh 74
BR - Brasile 68
FR - Francia 58
CA - Canada 49
SE - Svezia 45
GB - Regno Unito 41
IN - India 36
KR - Corea 31
BJ - Benin 28
FI - Finlandia 25
ID - Indonesia 24
AT - Austria 12
PL - Polonia 12
JP - Giappone 11
MX - Messico 11
ES - Italia 10
TR - Turchia 10
UA - Ucraina 10
IQ - Iraq 9
ZA - Sudafrica 9
AR - Argentina 8
NL - Olanda 8
CZ - Repubblica Ceca 6
GT - Guatemala 6
PH - Filippine 6
LT - Lituania 5
TW - Taiwan 5
EC - Ecuador 4
HN - Honduras 4
MA - Marocco 4
SA - Arabia Saudita 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
BE - Belgio 2
BS - Bahamas 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
IL - Israele 2
NG - Nigeria 2
PK - Pakistan 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BZ - Belize 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
Totale 3.405
Salva come PNG Salva come JPEG
Città #
San Jose 165
Council Bluffs 131
Ashburn 114
Singapore 109
Hong Kong 103
Dublin 99
Los Angeles 48
Beijing 43
Columbus 42
Milan 40
Munich 33
New York 33
Novara 33
Hanoi 30
Santa Clara 30
Cotonou 28
Ho Chi Minh City 26
Moscow 24
Lauterbourg 22
Phoenix 22
Chandler 21
Dallas 21
Seoul 21
Piemonte 19
Jakarta 18
Buffalo 17
Helsinki 17
Orem 17
Turin 17
Brooklyn 13
Denver 13
Falkenstein 13
West Jordan 13
Schaumburg 11
Vercelli 11
Atlanta 10
London 10
North Bergen 10
St Louis 10
Warsaw 10
Boardman 9
The Dalles 9
Tokyo 9
Toronto 9
Bremen 8
Gangbuk-gu 8
Montreal 8
Naples 8
São Paulo 8
Bologna 7
Chennai 7
Da Nang 7
Johannesburg 7
Ottawa 7
Stockholm 7
Turku 7
Assago 6
Guatemala City 6
Hillsboro 6
Lawrence 6
Menlo Park 6
Mexico City 6
Monza 6
Mumbai 6
Nuremberg 6
Palermo 6
Princeton 6
Rome 6
Vienna 6
Boston 5
Calgary 5
Florence 5
Frankfurt am Main 5
Paris 5
Philadelphia 5
Alessandria 4
Amsterdam 4
Ankara 4
Augusta 4
Brasília 4
Brno 4
Charlotte 4
Genoa 4
Houston 4
Manila 4
Newark 4
Olathe 4
Poplar 4
Richmond 4
San Salvador 4
Shanghai 4
Verona 4
Agrolândia 3
Biên Hòa 3
Brescia 3
Chicago 3
Greenville 3
Las Vegas 3
Manchester 3
Marseille 3
Totale 1.792
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 210
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 198
Vitamin D in Systemic Sclerosis: A Review 168
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 146
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 142
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 141
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death 130
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 124
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 123
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 121
Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study 120
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 119
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 115
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 113
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 112
Diagnostic value of systematic compression ultrasonography for the detection of unrecognized venous thromboembolism in patients admitted to an internal medicine ward for dyspnea 98
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 96
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 95
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 93
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 90
The price and value of therapeutic synergy in liver cancer 87
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? 83
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis 66
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world 62
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study 51
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence 45
Thinking outside the box: a case of unexplained ascites in an adult 28
Totale 3.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022130 0 0 0 12 11 11 18 3 17 16 8 34
2022/2023241 12 8 17 6 16 27 12 9 103 5 16 10
2023/2024183 13 14 7 7 21 12 27 15 13 14 14 26
2024/2025524 12 9 40 14 16 32 80 62 99 18 45 97
2025/20261.814 81 52 66 163 204 129 234 314 129 198 114 130
2026/2027540 90 142 126 182 0 0 0 0 0 0 0 0
Totale 3.465